drug · small molecule
patient view →inavolisib
Marketedupdated 2mo agoby F. Hoffmann-La Roche Ltd🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for breast neoplasm and 2 investigational indications.
targets
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
all catalysts(3)
approval · 3
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that